ZHIYAO TECHNOLOGY

zhiyao-technology-logo

Zhiyao Technology is a biotechnology (Biotechnology) company in the preclinical stage, driven by artificial intelligence technology, focusing on the research and development of small molecule innovative drugs. Zhiyao Technology combines artificial intelligence (AI) technology with experimental technologies such as medicinal chemistry, organic synthesis and the biological activity evaluation, a new generation of new drug discovery technology platforms will be established. Zhiyao Technology was established in August 2018.

#SimilarOrganizations #People #Financial #Website #More

ZHIYAO TECHNOLOGY

Industry:
Biotechnology Health Care Information Technology

Founded:
2018-08-01

Address:
Ningbo, Zhejiang, China

Country:
China

Website Url:
http://www.deepdrug.cn

Total Employee:
1+

Status:
Active

Total Funding:
1.51 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Content Delivery Network SSL By Default Font Awesome Mobile Non Scaleable Content Nginx ASP.NET IIS Ubuntu


Similar Organizations

healthwire-logo

Healthwire

Healthwire is a health-tech startup.

ihx-private-limited-logo

IHX Private Limited

India's largest healthcare data exchange

joinhealth-technology-logo

Joinhealth Technology

Joinhealth Technology is a Healthcare company.

medicom-technologies-logo

Medicom Technologies

Medicom is a SaaS Healthcare IT company.

Current Employees Featured

not_available_image

Jin Feng
Jin Feng Co-founder, Director of New Drug R&D @ Zhiyao Technology
Co-founder, Director of New Drug R&D

not_available_image

Huang Tao
Huang Tao Founder, CEO @ Zhiyao Technology
Founder, CEO

Founder


not_available_image

Huang Tao

not_available_image

Jin Feng

Investors List

qingsong-fund_image

Qingsong Fund

Qingsong Fund investment in Angel Round - Zhiyao Technology

Official Site Inspections

http://www.deepdrug.cn

  • Host name: 47.92.50.78
  • IP address: 47.92.50.78
  • Location: Hangzhou China
  • Latitude: 30.294
  • Longitude: 120.1619
  • Timezone: Asia/Shanghai

Loading ...

More informations about "Zhiyao Technology"

智药科技

关于我们. 智药科技是一家以人工智能技术为内核驱动、专注于计算药物研发技术的平台型公司,现为国家高新技术企业。See details»

国内AI公司简介7-智药科技(Deepdrug) - 知乎专栏

智药科技是一家以人工智能技术为内核驱动、专注于计算药物研发技术的平台型公司。通过将人工智能(AI)技术应用于小分子、蛋白(抗体、酶、工具蛋白等)、mRNA等药物领域,打造领先的 …See details»

DeepDrug: A general graph‐based deep …

Oct 17, 2023 DeepDrug takes both traditional sequence representation and structure-based graph representations as inputs to learn a more comprehensive representation for …See details»

DeepDrug: Applying AI for the Advancement of Drug Discovery

To address the issues of multidrug-resistance and newly emerging pathogens DeepDrug is developing computer aided drug design software utilizing Artificial Intelligence (AI)-based …See details»

Zhiyao Technology - Crunchbase Company Profile

Zhiyao Technology is a Shenzhen based Healthcare Start Up. Zhiyao Technology is a biotechnology (Biotechnology) company in the preclinical stage, driven by artificial intelligence technology, focusing on the research and development of …See details»

Q&A with DeepDrug Team Leader - LSU

The DeepDrug™ technology has been licensed by Skymount Medical. Dr. Mukhopadhyay led the DeepDrug™ team to compete in the IBM Watson Artificial Intelligence XPrize semifinals. He …See details»

DeepDrug as an expert guided and AI driven drug repurposing

Jan 15, 2025 DeepDrug advances drug-repurposing methodology in four aspects. Firstly, it incorporates expert knowledge to extend candidate targets to include long genes, …See details»

DeepDrug: A general graph-based deep learning framework for …

Ultimately, we apply DeepDrug to perform drug repositioning on the whole DrugBank database to discover the potential drug candidates against SARS-CoV-2, where 7 out of 10 top-ranked …See details»

智药科技 - deepdrug.cn

技术平台(Technology platform) 我们将人工智能(AI)技术应用于小分子、蛋白(抗体、酶、工具蛋白等)、mRNA等药物领域,打造领先的技术平台,提高药物发现的效率和成功率。目前我们打造了三大技术平台,分别是面向小分子药物 …See details»

DEEPDRUG: AN EXPERT-LED DIRECTED GRAPH NEURAL …

A novel AI-driven drug-repurposing method, DeepDrug, is used to identify a lead combination of previously FDA-approved drugs to treat AD by targeting the upstream genetic markers along …See details»

DeepDrug: A general graph‐based deep learning ... - ResearchGate

Oct 17, 2023 Download Citation | DeepDrug: A general graph‐based deep learning framework for drug‐drug interactions and drug‐target interactions prediction | Computational methods for …See details»

国内AI公司简介9-智睿医药(DM Intelligence) - 知乎专栏

智睿医药 (DM Intelligence)是一家专注于人工智能(AI)与 大数据技术 驱动的创新药物研发公司,致力于通过前沿的计算技术和多学科交叉方法,加速药物发现与开发进程。 公司核心团 …See details»

DeepDrug: An Expert-led Domain-specific AI-Driven Drug

Jul 6, 2024 DeepDrug offers a novel AI-and-big-data, expert-guided mechanism for new drug combination discovery and drug-repurposing across AD and other neuro-degenerative …See details»

DeepDrug Limited - webb-site.com

DeepDrug Limited. Key Data; FAQ; Domicile: Hong Kong: Type: Private, ltd by shares: Formed: 2016-06-22: Status: Striking off: Incorporation number: 66329741: Last check on companies …See details»

DEEPDRUG Trademark Application of Board of Supervisors of …

DEEPDRUG - Trademark Details. Status: 661 - Response After Non-Final Action - Entered. Serial Number. 90703316. Word Mark. DEEPDRUG. Status. 661 - Response After Non-Final Action …See details»

Streamlit

邮箱: support@deepdrug.com 电话:(86) 0755-26656756 注意:此为Demo版,因此在设计序列长度和打分序列数量上均有限制,如果您想使用完整版DeepRNA®, 请与我们联系。See details»

‪Qiao Liu‬ - ‪Google 学术搜索‬ - Google Scholar

Xuegong Zhang Tsinghua University 在 tsinghua.edu.cn ... DeepDrug: a general graph‐based deep learning framework for drug‐drug interactions and drug‐target interactions prediction. Q …See details»

EdoPriyo13/deepdrug - GitHub

DeepDrug outperforms other state-of-the-art published methods both in terms of accuracy and robustness in predicting DDIs and DTIs with varying ratios of positive to negative training data …See details»

DeepDRK: a deep learning framework for drug repurposing …

Recent pharmacogenomic studies that generate sequencing data coupled with pharmacological characteristics for patient-derived cancer cell lines led to large amounts of multi-omics data for …See details»

linkstock.net © 2022. All rights reserved